Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200056799Phase 4Not yet recruiting
Phase 4, randomised trial of remimazolam in cardiac surgery (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Heart rate, Mean arterial pressure and 2 more. Planned start Feb 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200056799.